芬戈莫德
多发性硬化
医学
实验性自身免疫性脑脊髓炎
免疫学
药理学
血脑屏障
细胞因子
中枢神经系统
内科学
作者
С. М. Лунин,Г. Н. Енгалычева,Glushkova O.V.,Pragnesh Parmar,Kudryavtseva A.P. Kudryavtseva A,Novoselova T.V.,Maria G. Stathopoulou,M. K.,Goncharov R.G.,Kolawole Ikeoluwapo O
标识
DOI:10.2174/011570159x372166250619064636
摘要
Both fingolimod and Prdx6 produced beneficial effects, while Prdx6 may be useful for ameliorating the side effects of anti-lymphocytic drugs. Accounting for literature data that discontinuation of MS treatment is very likely to lead to a severe MS rebound, a drug that prevents the rebound should be useful.
科研通智能强力驱动
Strongly Powered by AbleSci AI